Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused heteroaryl derivatives as orexin receptor antagonists

Fused heteroaryl derivatives as orexin receptor antagonists

US Patent 10526336 · Granted Jan 7, 2020

Estimated economic value: $173,493,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of s2025
Cyclohexylglycine derivatives as selective cytotoxic agents2025
Crystal form of pyrimidine sulfonamide compound and preparation method therefor2025
5-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
6-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
Fused tri-cyclic compound as PDE3/PDE4 dual inhibitor2024
Substituted aminopyridine compounds as EGFR inhibitors2024
Substituted aminopyridine compounds as EGFR inhibitors2024
Bicyclic compound that acts as CRBN protein regulator2024
Dihydroorotate dehydrogenase inhibitors2023
Medical application of pyrimidine sulfonamides derivatives2023
Dihydroorotate dehydrogenase inhibitors2022